Global Cancer Biological Therapy Market 2018 Size, Development Status, Type and Application, Segmentation, Forecast by 2023

WiseGuyReports.com adds “Cancer Biological Therapy Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023”reports to its database.

Pune, India - January 12, 2018 /MarketersMedia/ —

Cancer Biological Therapy Market:

Executive Summary

Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. There are various types of biological therapies, which inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.

The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a CAGR of 4.7% during the forecasted period.  

The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.

On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, interferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.

On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023. 

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Players

The leading market players in the global cancer biological therapy market include Merck Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Bristol-Myers Squibb, Celgene, ELI Lilly and Company, EnGeneIC, and Pfizer

Study objectives

To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global cancer biological therapy market
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global cancer biological therapy market.
To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
To provide economical factors that influences the global cancer biological therapy market
To provide detailed analysis of the value chain and supply chain of the global cancer biological therapy market

Target Audience

Pharmaceutical Companies
Pharmaceutical Suppliers
Cancer Research Organizations
Potential Investors
Key Executive (CEO and COO) and Strategy Growth Manager
Reaserch Companies

For further information on this report, visit - https://www.wiseguyreports.com/enquiry/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Findings

North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016

The reports also covers regional analysis

North America
o US

o Canada

Europe
o Germany

o France

o U.K.

o Italy

o Spain

o Rest of Europe

Asia Pacific
o Japan

o China

o India

o Republic of Korea

o Rest of Asia-Pacific

Middle East & Africa
o Middle East

o Africa

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1793685

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: Wise Guy Research Consultants Pvt Ltd
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349 (US); +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/global-cancer-biological-therapy-market-2018-size-development-status-type-and-application-segmentation-forecast-by-2023/286775

For more information, please visit https://www.wiseguyreports.com/reports/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Source: MarketersMedia

Release ID: 286775

Latest News

The Latest: Iranian protesters confront police in Tehran

Jun 25, 2018

DUBAI, United Arab Emirates — The Latest on developments in Iran (all times local): 3:35 p.m. Videos posted on social media appear to show Iranian demonstrators confronting police officers in front of Iran's parliament in Tehran. The footage on Monday shows tear gas in the air and protesters screaming, "They attacked us with tear gas!" Another man is heard shouting: "Come back!" The protest came after demonstrators in the Iranian capital swarmed its historic Grand Bazaar earlier in the day and forced shopkeepers to close their stalls in apparent anger over the Islamic Republic's troubled economy. At the end of...

Reports: Protesters swarm Iran's Grand Bazaar in Tehran

Jun 25, 2018

DUBAI, United Arab Emirates — Protesters in the Iranian capital swarmed its historic Grand Bazaar on Monday, news agencies reported, and forced shopkeepers to close their stalls in apparent anger over the Islamic Republic's troubled economy, months after similar demonstrations rocked the country. The unplanned demonstration came a day after protests forced two major shopping centers for mobile phones and electronics to close in Tehran. It also signaled widespread unease beneath the surface in Iran in the wake of President Donald Trump's decision to withdraw America from Tehran's nuclear deal with world powers. It wasn't immediately clear who led the...

Uber argues it should remain in business in London

Jun 25, 2018

LONDON — Uber argued Monday that is should be allowed to keep driving on the streets of London, telling a court that the ride-hailing app has made significant changes since a regulator refused to renew the company's operating license last year. Lawyers for the company opened their case in an effort to overturn Transport for London's ruling in September that Uber was not a "fit and proper" company after repeated lapses in corporate responsibility. Uber attorney Tom de la Mare said the ruling led to "wholesale change" at the company. "It's profound and very much for the better," he said...

Harley, stung by tariffs, shifts some production overseas

Jun 25, 2018

MILWAUKEE — Harley-Davidson, facing rising costs from new tariffs, will begin shifting the production of motorcycles heading for Europe from the U.S. to factories overseas. The famed motorcycle maker said in a regulatory filing Monday that European Union tariffs on its motorcycles exported from the U.S. jumped from 6 percent to 31 percent. Harley-Davidson Inc. said that it will not raise its prices due to "an immediate and lasting detrimental impact to its business in the region."

UK lawmakers set to decide on Heathrow expansion

Jun 25, 2018

LONDON — British lawmakers are set to vote Monday on whether to expand Europe's biggest airport in what the government has described as the most important transportation decision in a generation. The decision on a third runway at Heathrow airport comes after years of study and debate over the building of the first full runway in the southeast of the country since World War II. Approval of the 14 billion-pound ($18.6 billion) project is certain to be challenged in the courts. Prime Minister Theresa May's government believes expansion is the right move for Britain, a signal showing national commitment to...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com